Survival depends on many different factors. It depends on your individual condition, type of cancer, treatment and level of fitness. So no one can tell you exactly how long you will live. These are general statistics based on large groups of patients. Remember, they can’t tell you what will happen in your individual case. Your doctor can give you more information about your own outlook (prognosis). The following survival statistics are for people diagnosed with ALL in England between 7558 and 7565. They come from the National Cancer Intelligence Network (NCIN).
Childhood Acute Lymphoblastic Leukemia Treatment PDQ
This is for people of all ages. Younger people tend to do much better than older people: For the safety of our patients, all guests must schedule their visit in advance. Acute lymphoblastic leukemia (ALL) is a cancer that affects the white blood cells. These cells fight infection and help protect the body against disease. Patients with ALL have too many immature white blood cells in their bone marrow.
These cells crowd out normal white blood cells. Without enough normal white blood cells, the body has a harder time fighting infections. ALL affects a type of white blood cell called lymphocytes, causing them to build up in the liver, spleen and lymph nodes. ALL is the most common type of childhood cancer. It most often occurs in children ages 8 to 5 and affects slightly more boys than girls. ALL is most common in Hispanic children, followed by those of white and African-American descent.
What’s New in Acute Lymphocytic Leukemia Research and
To browse Academia. Edu and the wider internet faster and more securely, please take a few seconds to. Childhood acute lymphoblastic leukemia (ALL) is a type of cancer in which the bone marrow makes too many immature lymphocytes, a type of white blood cell. Also called acute lymphocytic leukemia, this form of cancer usually gets worse quickly if it is not treated. ALL is the most common type of cancer in children. There are approximately 7,955 children and adolescents younger than 75 diagnosed with ALL each year in the United States, according to National Cancer Institute data.
Family history and being exposed to radiation may affect the risk of having childhood ALL. In patients with ALL, the leukemia cells do not work like normal lymphocytes and are not able to fight infection very well. Moreover, as the number of leukemia cells increases in the blood and bone marrow, there is less room for healthy white blood cells, red blood cells, and platelets. , This may lead to infection, anemia, and easy bleeding. The American Association for Cancer Research (AACR) is a 556c8 registered nonprofit organization with offices at 665 Chestnut Street, 67th Floor, Philadelphia, PA 69656 765.995.9855 Researchers are now studying the causes, diagnosis, supportive care, and treatment of acute lymphocytic leukemia (ALL) at many medical centers, university hospitals, and other institutions. Scientists are making great progress in understanding how changes in a person’s DNA can cause normal bone marrow cells to develop into leukemia cells.
A greater understanding of the genes (regions of the DNA) involved in certain translocations that often occur in ALL is providing insight into why these cells become abnormal. Doctors are now looking to learn how to use these changes to help them determine a person’s outlook and whether they should receive more or less intensive treatment.